| Vol. 18.01 – 17 January, 2024 |
| |
|
|
| Researchers conducted a Phase I trial of CAR T-EGFRvIII cells administered concomitantly with the anti-PD1 monoclonal antibody pembrolizumab in patients with newly diagnosed, EGFRvIII+ glioblastoma. [Nature Cancer] |
|
|
|
|
PUBLICATIONSRanked by the impact factor of the journal |
| | Investigators tested whether disease-associated TREM2 variants contribute to the pathology via altered splicing. Their findings revealed an unanticipated complexity of pathogenic variation in TREM2, in which effects on post-transcriptional gene regulation and protein function often coexist. [Brain] |
|
|
|
| Scientists identified cell clusters representing various neuron types, glia, endothelial cells, pericytes, fibroblasts, and T cells and investigated cell type–dependent alterations in gene expression in Parkinson’s disease. [Science Advances] |
|
|
|
| Investigators supported the hypothesis that the Ventral Tegmental Area dopaminergic system integrity plays a key role in hippocampal Parvalbumin interneurons function and survival, disclosing a relevant contribution of the reduced dopaminergic tone to aberrant gamma-waves, hippocampal hyperexcitability, and epileptiform activity in early Alzheimer’s disease. [Molecular Psychiatry] |
|
|
|
| Researchers obtained skin fibroblasts from members of amyotrophic lateral sclerosis and frontotemporal dementia family. They reprogrammed these fibroblasts to induced pluripotent stem cells (iPSCs) and generated cortical organoids as well as induced stage-wise differentiation of the iPSCs to neurons. [Journal Of Pathology] |
|
|
|
| The authors investigated the expression of interferon-induced transmembrane protein 3 (IFITM3) in glioma datasets culled from The Cancer Genome Atlas and Chinese Glioma Genome Atlas. Primary glioblastoma multiforme stem cells were cultured and identified in vitro. [Cell Death & Disease] |
|
|
|
| Scientists investigated and elucidated the cell signaling pathways implicated in the developmental maturation of oligodendrocytes using human fetal neural stem cells –derived primary oligodendrocytes and MO3.13 cell line. [Molecular Neurobiology] |
|
|
|
| Researchers developed a well-defined, fully synthetic hydrogel system that allowed for the precise control of the concentration of cationic trimethylaminoethyl acrylate molecules associated with the polymer. They observed a strong correlation between cationic charge concentration with NSPC survival. [ACS Biomaterials Science & Engineering] |
|
|
|
| Scientists investigated the relevance between RNA modification regulators and glioblastoma angiogenesis. They discovered that ALKBH5 knock-down of U87 cells could decrease the pro-angiogenesis ability of U87 GBM cells. [Scientific Reports] |
|
|
|
| Mouse embryonic brain NSCs were used to investigate the expression changes of Ascl1, Hes1, and Oligo2 in mRNA and protein levels during electric field-induced neuronal differentiation. [Molecular Biology Reports] |
|
|
|
|
| The authors present the current evidence for and understanding of inflammasome activation in neurological diseases and discuss current and potential interventional strategies that target inflammasome activation to mitigate its pathological consequences. [Nature Reviews Neurology] |
|
|
|
| The authors summarize the production and function of IL-6 as well as its downstream signaling pathways. Moreover, they provide a comprehensive review of the roles of IL-6 in neurodegenerative disorders and its potential clinical application. [Neurochemical Research] |
|
|
|
|
| A new and potentially controversial method, growing tiny, brainlike structures called organoids in a dish from human fetal brain tissue, could provide a realistic model and improve the study of developmental disorders or brain cancers. [Science] |
|
|
|
| Apertura Gene Therapy unveiled its proprietary engineered Adeno-Associated Virus (AAV) capsids that bind to the human Transferrin Receptor 1. This transportation mechanism mediates the crossing of the blood-brain barrier to enable gene therapy delivery throughout the central nervous system. [Aperture Gene Therapy] |
|
|
|
|
| February 14 – 16, 2024 Hinxton, England, United Kingdom |
|
|
|
|
|
| Baylor College of Medicine – Houston, Texas, United States |
|
|
|
| University of Birmingham – Birmingham, England, United Kingdom |
|
|
|
| Human Technopole – Milan, Italy |
|
|
|
| University of Michigan – Ann Arbor, Michigan, United States |
|
|
|
| The Hong Kong University of Science and Technology – Guangzhou, China |
|
|
|
|